申请人:Boehringer Ingelheim GmbH
公开号:US04191776A1
公开(公告)日:1980-03-04
Compounds of the formula ##STR1## wherein R.sub.1 is hydrogen, fluorine, chlorine, bromine, methyl, methoxy, methylthio or cyano; R.sub.2 is hydrogen or fluorine; R.sub.3 is carboxyl, (alkoxy of 1 to 6 carbon atoms)-carbonyl, methoxy-(alkoxy of 1 to 6 carbon atoms)-carbonyl, (alkenyloxy of 2 to 6 carbon atoms)-carbonyl, (aralkoxy of 7 to 12 carbon atoms)-carbonyl, phenoxy-carbonyl or pyridyl-methoxy-carbonyl, A is (alkyl of 1 to 3 carbon atoms)-methylene, m is 1 or 2; and n is 0, 1, 2 or 3; and, when R.sub.3 is carboxyl, non-toxic salts thereof formed with an inorganic or organic base. The compounds as well as the salts are useful as antithrombotics, anticholesteremics and anticoagulants.
式为##STR1##的化合物,其中R.sub.1为氢、氟、氯、溴、甲基、甲氧基、甲硫基或氰基;R.sub.2为氢或氟;R.sub.3为羧基、(1至6个碳原子的烷氧基)-羰基、甲氧基-(1至6个碳原子的烷氧基)-羰基、(2至6个碳原子的烯烃氧基)-羰基、(7至12个碳原子的芳基氧基)-羰基、苯氧基-羰基或吡啶基-甲氧基-羰基,A为(1至3个碳原子的烷基)-亚甲基,m为1或2;n为0、1、2或3;当R.sub.3为羧基时,与无机或有机碱形成的非毒性盐。这些化合物及盐可用作抗血栓、抗胆固醇和抗凝剂。